Phosphatidylinositol 3-Kinases, antagonists & inhibitors

All categories
DBCAT001500Pharmacologic class

A DrugBank category of 16 drugs. 3 of them are approved.

Also known as
Phosphatidylinositol 3-Kinase, antagonists & inhibitors
Drugs

What you can answer from here — as of July 17, 2023

16DrugsEach linked to its full drug card
Listed above
10Drug targetsEvery drug–target pair in the class, with bond type
Sign in
47Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
2Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Phosphatidylinositol 3-Kinases, antagonists & inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In